Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The D-Alanyl-D-alanine terminus of cell wall peptidoglycan is a short peptide sequence (D-Ala-D-Ala) found at the end of the stem peptides within nascent bacterial peptidoglycan precursors, especially abundant in Gram-positive bacteria. It is critical for the final cross-linking (transpeptidation) reactions that provide bacterial cell wall rigidity and structural integrity[1][3][7]. This motif is the direct binding site for glycopeptide antibiotics such as vancomycin, which block the cross-linking of new cell wall subunits by capping this dipeptide and thereby halting cell wall biosynthesis, leading to bacteriolysis. Resistance can develop by alteration of this terminus, such as replacing the terminal D-Ala with D-lactate (D-Ala-D-Lac), reducing drug efficacy[6]. Targeting this motif underpins the mechanism of action for a major class of antibiotics used in serious infections due to Gram-positive bacteria.
Inhibition of cell wall synthesis by sterically blocking transpeptidase (DD-transpeptidase) cross-linking at the D-Ala-D-Ala terminus Direct binding by glycopeptide antibiotics prevents addition of new peptidoglycan subunits
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on D-Alanyl-D-alanine terminus of cell wall peptidoglycan.